Davis Stroop
Cincinnati Children's Hospital Medical Center
9 Papers
103 Citations
Davis Stroop is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Insulin resistance & Body mass index. The author has an hindex of 7, co-authored 9 publications. Previous affiliations of Davis Stroop include Boston Children's Hospital & University of Cincinnati Academic Health Center.
Chat about Author
Papers
Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Charles J. Glueck,John A. Morrison,John A. Morrison,Lisa Aronson Friedman,Naila Goldenberg,Davis Stroop,Davis Stroop,Ping Wang +7 more
TL;DR: It is suggested that if adolescent girls achieve adiposity equal to girls with PCOS, they then acquire major components of the metabolic syndrome, and excluding high FT and waist circumference, comparable increased cardiovascular disease risk.
68
Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.
TL;DR: Oligomenorrhea, PCOS, hyperandrogenism, low levels of sex hormone-binding globulin, childhood insulin, and metabolic syndrome at age 14 years may represent a critical, reversible pathway for the development of MetS and class III obesity in young adulthood.
63
Population-specific alleles: the polymorphism (K121Q) of the human glycoprotein PC-1 gene is strongly associated with race but not with insulin resistance in black and white children.
John A. Morrison,Ralph A. Gruppo,Charles J. Glueck,Davis Stroop,Robert N. Fontaine,Ping Wang,Kathleen L Smith +6 more
TL;DR: The K121Q polymorphism was not associated with insulin, glucose, or HOMA IR measures in black or white children, however, the QQ genotype was population-specific, encompassing most black children versus 1% to 3% of white children.
33
Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years later.
TL;DR: Paradoxically high adiponectin levels in obese 16 year old girls protects against metabolic syndrome and its components at age 23 years.
19
Adolescent oligomenorrhea in a biracial schoolgirl cohort: a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 to 25 years.
TL;DR: Age 14 waist circumference, oligomenorrhea with hyperandrogenism (polycystic ovary syndrome), black race, oligomanorrhea frequency at ages 14 to 19, and age 14 sex hormone binding globulin were independently associated with IR at ages 19 to 24, potentially facilitating primary prevention of IFG, T2DM, and hyperinsulinemia.
17